CO-DIAGNOSTICS, INC. (CODX) Free cash flow 2016–2025
CO-DIAGNOSTICS, INC. (CODX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$29.8MFY2025 · since FY2016: -$1.3M → -$29.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$29.8M | +0.2% |
| FY2024 | -$29.9M | -27.5% |
| FY2023 | -$23.4M | -556.1% |
| FY2022 | $5.1M | -87.3% |
| FY2021 | $40.4M | +47.5% |
| FY2020 | $27.4M | +585.8% |
| FY2019 | -$5.6M | -36.8% |
| FY2018 | -$4.1M | -23.4% |
| FY2017 | -$3.3M | -152.2% |
| FY2016 | -$1.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CODX financial trends
CODX RevenueCODX Net incomeCODX Net marginCODX Gross profitCODX Gross marginCODX Operating incomeCODX Operating marginCODX Operating cash flowCODX Capital expendituresCODX Return on equityCODX Stock buybacksCODX Dividends paidCODX Total assetsCODX Total liabilitiesCODX Shareholders’ equityCODX overview →